Healthcare providers use various medications to treat vasculitis, a sometimes severe condition that may cause organ damage or death. Treatment for vasculitis is evolving as newer therapies become ...
Frailty emerged as an independent risk factor for severe infection and end-stage renal disease or death across different age ...
来自MSN2 个月
What Is Vasculitis?
Over-the-counter anti-inflammatory medications, such as Advil (ibuprofen) or Aleve (naproxen), may be enough to reduce pain and discomfort for mild vasculitis. More severe vasculitis may require ...
IgA vasculitis is a rare systemic vasculitis in adults, frequently more severe than in paediatric age. It manifests with cutaneous, articular, gastrointestinal and renal involvement. We present a case ...
Objectives Severe infections contribute to morbidity and mortality in antineutrophil cytoplasm antibody-associated vasculitis (AAV). This study aimed to identify risk factors associated with severe ...
Primary central nervous system (CNS) vasculitis is a rare ... Headaches are usually severe and persistent and may be generalized or localized; they are rarely a thunderclap headache, which ...
Background Cutaneous vasculitis (CV) can be a clinical manifestation of a severe infection. In such cases a delayed diagnosis or the use of immunosuppressive therapy may impair the prognosis.
Researchers led by the University Hospital Zurich have identified cases of sterile intraocular inflammation, including severe retinal vasculitis, associated with faricimab injections used to treat eye ...
Treatment results in remission for about 85% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis ... which can result in severe kidney damage.
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your ...
Sterile intraocular inflammation is rare, but can be potentially severe following treatment with faricimab, a real world case series shows.
Rituximab is a promising alternative treatment option for severe cryoglobulinemic vasculitis and nephritis. Although the optimal treatment strategy in HCV-related cryoglobulinemia has not been ...